CYCN (Cyclerion Therapeutics) Buyback Yield %: -5.15 (As of Sep. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CYCN Cyclerion Therapeutics Inc CYCN
33 GF Score
Price $23.94
! 3 Warning Signs
View Full Analysis

What is Cyclerion Therapeutics Buyback Yield %?

Cyclerion Therapeutics CYCN -20.19% 33 Buyback Yield % is -5.15 as of Sep. 10, 2026. GuruFocus rates CYCN with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 697 Biotechnology companies, Cyclerion Therapeutics ranks better than 62.55% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Cyclerion Therapeutics's current buyback yield was -5.15%.

Cyclerion Therapeutics Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Cyclerion Therapeutics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyclerion Therapeutics Buyback Yield % Chart

Cyclerion Therapeutics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only -40.86 0.00 0.00 0.00 -25.65

Cyclerion Therapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.92 -16.17 -25.65 1.94 -5.62

CYCN vs LPCN, TPST, BCDA: Buyback Yield % Comparison

For the Biotechnology subindustry, Cyclerion Therapeutics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyclerion Therapeutics Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cyclerion Therapeutics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Cyclerion Therapeutics's Buyback Yield % falls into.


CYCN
33GF Score
Cyclerion Therapeutics Inc CYCN
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cyclerion Therapeutics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Cyclerion Therapeutics's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-0.13 + 1.375) / 4.853939454
=-25.65%

Cyclerion Therapeutics's annualized Buyback Yield for the quarter that ended in Jun. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0.825) / 14.688869381
=-5.62%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -5.15 mean?
Cyclerion Therapeutics (CYCN) has a Buyback Yield % of -5.15 as of Sep. 10, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Cyclerion Therapeutics and its competitors. According to the industry distribution chart, Cyclerion Therapeutics ranks #261 out of 697 companies in the Biotechnology industry, placing it in the top 37.4%.
Is Cyclerion Therapeutics' Buyback Yield % too high?
Cyclerion Therapeutics' current Buyback Yield % is -5.15. Based on the distribution chart, Cyclerion Therapeutics ranks #261 out of 697 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Cyclerion Therapeutics has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Cyclerion Therapeutics' Buyback Yield % compare to LPCN and TPST?
According to the Biotechnology industry distribution chart, Cyclerion Therapeutics ranks #261 out of 697 companies for Buyback Yield %. This puts Cyclerion Therapeutics in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Cyclerion Therapeutics and its competitors. Cyclerion Therapeutics's current Buyback Yield % is -5.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyclerion Therapeutics stock overvalued right now?
Cyclerion Therapeutics (CYCN) has a current Buyback Yield % of -5.15. The current Buyback Yield % is -5.15. Cyclerion Therapeutics' overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Cyclerion Therapeutics (CYCN), the current Buyback Yield % is -5.15 as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cyclerion Therapeutics Business Description

Address 245 First Street, 18th Floor, Cambridge, MA, USA, 02142
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.
33GF Score

Get the complete analysis for CYCN

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.94
Price